"Shao KD"[Author] - Search Results

Year	Number of Results
2007	1
2011	1
2014	2
2015	1
2018	1
2019	2
2020	1
2021	0

1

Ganoderma proteins and their potential applications in cosmetics.

Li LD, Mao PW, Shao KD, Bai XH, Zhou XW. Li LD, et al. Among authors: shao kd. Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9239-9250. doi: 10.1007/s00253-019-10171-z. Epub 2019 Oct 29. Appl Microbiol Biotechnol. 2019. PMID: 31659419 Review.

2

Multiple risks analysis for aplastic anemia in Zhejiang, China: A case-control study.

Wu LQ, Shen YY, Zhang Y, Kuang YM, Fang BM, Wang ZZ, Fu LJ, Shao KD, Shen JP, Zhou YH, Shen YP, Ye BD, Zheng ZY, Chen JF, Lin SY. Wu LQ, et al. Among authors: shao kd. Medicine (Baltimore). 2019 Feb;98(8):e14519. doi: 10.1097/MD.0000000000014519. Medicine (Baltimore). 2019. PMID: 30813154 Free PMC article.

3

Guilu Erxian Glue () Inhibits Chemotherapy-Induced Bone Marrow Hematopoietic Stem Cell Senescence in Mice May via p16^INK4a-Rb Signaling Pathway.

Wang J, Ying YY, Chen ZH, Shao KD, Zhang WP, Lin SY. Wang J, et al. Among authors: shao kd. Chin J Integr Med. 2020 Nov;26(11):819-824. doi: 10.1007/s11655-020-3098-3. Epub 2020 Sep 11. Chin J Integr Med. 2020. PMID: 32915425

4

[Research advance on the role of ubiquitin proteasome pathway in acute promyelocytic leukemia].

Liu TT, Wu DJ, Ye BD, Shao KD, Sun J, Zhou YH. Liu TT, et al. Among authors: shao kd. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):232-6. doi: 10.7534/j.issn.1009-2137.2014.01.046. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 24598685 Review. Chinese.

5

[Anti-lung cancer mechanisms of diterpenoid tanshinone via endoplasmic reticulum stress-mediated apoptosis signal pathway].

Lou ZH, Xia RM, Li XJ, Cheng RB, Shao KD, Zhang GJ. Lou ZH, et al. Among authors: shao kd. Zhongguo Zhong Yao Za Zhi. 2018 Dec;43(24):4900-4907. doi: 10.19540/j.cnki.cjcmm.20180725.002. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 30717537 Chinese.

6

Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients.

Ye BD, Zhang X, Shao KD, Chen D, Zhang Y, Wu DJ, Yu QH, Shen JP, Shen YP, Zhou YH. Ye BD, et al. Among authors: shao kd. Chin J Integr Med. 2014 Dec;20(12):903-9. doi: 10.1007/s11655-014-2026-9. Epub 2014 Nov 27. Chin J Integr Med. 2014. PMID: 25428338 Clinical Trial.

7

Multi-central clinical research into treating 80 cases of chronic thrombocytopenia with qi-supplementing and yin-nourishing therapy and western medicine.

Zhou YH, Wei KM, He LY, Sun XM, Shao KD, Fang BM, Shen YP, Ye BD, Shen JP, Lin SY, Chen ZL, Cai GL, Chen J, Gao YT, Wang XQ, Zhu JJ. Zhou YH, et al. Among authors: shao kd. J Tradit Chin Med. 2011 Dec;31(4):277-81. doi: 10.1016/s0254-6272(12)60004-1. J Tradit Chin Med. 2011. PMID: 22462231 Free article. Clinical Trial.

8

[Significance of PLSCR1 in Matrine Induced Differentiation of ATRA Resistant APL Cells].

Wu DJ, Liu TT, Zhou QH, Sun J, Shao KD, Ye BD, Zhou YH. Wu DJ, et al. Among authors: shao kd. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Nov;35(11):1345-50. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26775483 Chinese.

9

Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by shengxueling.

Shao KD, Zhou YH, Shen YP, Ye BD, Gao RL, Zhang Y. Shao KD, et al. Chin J Integr Med. 2007 Mar;13(1):33-6. doi: 10.1007/s11655-007-0033-9. Chin J Integr Med. 2007. PMID: 17578315 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results